Scientists probe hidden immune cells to save failing kidney transplants

NCT ID NCT07134491

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Mar 21, 2026 · Last updated Jun 19, 2026 · Updated 16 times

Summary

This study looks at why some kidney transplant patients reject their new kidney despite treatment. Researchers will collect and study B cells (a type of immune cell) from 45 adult patients who need a kidney biopsy or have their transplant removed. They hope to find new clues about what triggers rejection and how to better prevent it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nephrology department, Hôpital Pitié Salpêtière
RECRUITING

Paris, 75013, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Nephrology department, Tenon hospital
NOT_YET_RECRUITING

Paris, 75020, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

acute transplant rejection Rejection, Psychology transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION